Does the cannabis industry have a monopoly problem?

On June 24, US Department of Justice whistleblower John Elias testified that attorney general William Barr ordered investigations of 10 cannabis mergers in the 2019 fiscal year based on personal dislike of the industry. If that sounds like a lot, he said, it is. According to Elias’s testimony (pdf), those reviews accounted for 29% of the antitrust division’s full merger investigations during that period.

US Retail Cannabis Sales On Pace To Rise 40 Percent, Eclipsing $15 Billion In 2020

Total U.S. sales could rise as high as $37 billion by 2023, Marijuana Business Daily data finds. Meanwhile, the coronavirus pandemic has thrown a huge curveball at projections.

Retail sales of medical and recreational cannabis in the United States are on pace to eclipse $15 billion by the end of 2020, an increase of approximately 40% over 2019 sales figures, according to exclusive projections from the 2020 edition of the Marijuana Business Factbook.

In Cannabis Industry, Profitability and Data Security Go Hand-in-Hand

The issues surrounding legalized cannabis and data security create a multi-front battle that can be incredibly challenging from a legal and technological perspective.

No longer operating in the margins, the highly profitable, and highly regulated, legalized cannabis industry has ably, as well as nimbly, pushed its sales through to mainstream business. Total legal sales of cannabis in the U.S.

Are Good Times Coming for Aurora Cannabis?

After an unanticipated third quarter, this pot company is making some hard decisions. Will the efforts pay off?

Once a favorite marijuana stock, Edmonton, Alberta-based Aurora Cannabis (NYSE:ACB) saw its worst days in 2019, with declining revenues, negative profitability, and a sinking leadership team eventually pushing its stock to the verge of being delisted.

Cannabis research stalled by federal inaction

US scientists face numerous barriers to studying health effects of cannabis

Researchers in the US who want to investigate the medical benefits and risks of cannabis are frustrated. They would like to evaluate the wide array of cannabis products sold in states where cannabis is legal, but federal law prohibits them from doing so because cannabis is still illegal at the federal level.

The Surprising Reason the U.S. May Be Reluctant to Legalize Marijuana

It's all about the green. No, the other green.

Amid the chaos of 2020, which has included a stock market crash, the coronavirus disease 2019 (COVID-19) pandemic, and even some hoopla about the arrival of murder hornets, there's still the realization that this is an election year. In a little over four months, Americans across the country will be heading to the polls or mailing in their ballots to determine who'll lead the U.S. for the next four years.

Aurora Cannabis’s Cost-Cutting Measures Made Analysts Bullish

Aurora Cannabis (NYSE:ACBannounced some business transformation plans on June 23. The plans included cost savings and margin improvement. The company also announced a reduction in the workforce, which is definitely not positive news for the employees. However, the news went well with analysts. They’re happy with Aurora Cannabis’s progress with being on track to achieve positive EBITDA. Aurora Cannabis stock closed with a gain of 0.66% on Wednesday.